ImaginAb
Clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.
Launch date
Employees
Market cap
-
Enterprise valuation
€47—70m (Dealroom.co estimates Jun 2021.)
Inglewood California (HQ)
Authorizing premium user...